Growth screening in children aged 3–5 years: a useful tool for public health programs in community pediatrics
-
Simon Kayemba-Kay’s
,
Odile Maillet
Abstract
Background
About 90% of children grow up normally and attain a final height within their genetic target. In children with intrauterine growth restriction (IUGR), up to 10% will not catch up spontaneously. Turner syndrome is often diagnosed late, and a number of growth-stunted children go undiagnosed and untreated.
Objectives
Our primary aim was to evaluate the prevalence of stunted growth in preschool-aged children. Our secondary aim was to evaluate growth patterns in children belonging to four ethnic groups in Dreux district, France.
Methods
Body weight, height and body mass index (BMI) were collected for children aged 3–5 years during systematic community visits. Birth variables, family history of short stature, maternal smoking, ethnic origin, etc. were also recorded. Pubertal status was staged as per Tanner’s method. Parents were instructed to attend the hospital growth clinics if their child’s height was <−2.0 standard deviation score (SDS).
Results
Five hundred ninety-three children were screened (301 boys, 289 girls). The mean age was 4.33 ± 0.76 standard deviation (SD) years, and 48% were Caucasians, 13.7% were North Africans, 2.5% were Black Africans, 0.8% were Asians, 1.5% included others and the ethnicity was not specified in 33.5% of the cases. 91.5% of children were term-born and 8.5% were preterm. 84.2% of children were appropriate for gestational age (AGA) and 9.4% were small for gestational age (SGA). At 5 years of age, 22.2% of macrosomic North African children were overweight. Catch-up growth was complete in 98% children, 11/540 were short statured, 8/11 attended our growth clinics (seven short statured and one micropenis) and three were started on recombinant human growth hormone (rhGH).
Conclusions
Growth screening programs are important and useful tools for public health. There is a need for clear objectives, proper training and automated data collection tools, along with easy access to growth specialists.
Acknowledgments
We are very thankful to Luigi Di Nicola from the IPSEN International for his constant support; we also express our deep gratitude to doctors Jean-Louis Roudière, Isabelle Brin and Florence Nicot of Protection Maternelle et Infantile, Dreux district and all their nurses who carried out the field work. Lastly, we thank all the children and their parents for their participation in this study. We are wholeheartedly indebted to the IPSEN International for the financial support without which this work would not have been possible.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: The corresponding author received research funding from IPSEN International.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Saenger P, Czernichow P, Hugues I, Reiter EO. Small for gestational age: short stature and beyond. Endoc Rev 2007;28:219–51.10.1210/er.2006-0039Search in Google Scholar
2. Gardosi J. New definitions of small for gestational age based on the fetal growth potential. Horm Res 2006;65(Suppl 3):142–51.10.1159/000091501Search in Google Scholar
3. Kayemba-Kay’s S, Hindmarsh P. Catch-up growth: an overview. Pediatr Endocrinol Rev 2006;3:365–78.Search in Google Scholar
4. Brook CG. In: Growth assessment in childhood and adolescence. London, UK: Blackwell Edit, 1982:9–82.Search in Google Scholar
5. Mohamed S, Roche EF, Hoey HM. Mode of initial presentation and chromosomal abnormalities in Irish patients with Turner syndrome: a single-center experience. J Pediatr Endocrinol Metab 2015;28:1215–8.10.1515/jpem-2014-0287Search in Google Scholar
6. Hjerrild BE, Mortensen KH, Gravholt CH. Turner syndrome and clinical treatment. Br Med Bull 2008;86:77–93.10.1093/bmb/ldn015Search in Google Scholar
7. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth hormone research society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008;93:4210–7.10.1210/jc.2008-0509Search in Google Scholar
8. Lee AC, Katz J, Blencowe H, Cousens S, Kozuki N, et al. National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010. Lancet Glob Health 2013;1:e26–36.10.1016/S2214-109X(13)70006-8Search in Google Scholar
9. Amadieu JF. Les discriminations sur l’apparence dans la vie professionnelles et Sociales. Paris, France: TNS Sofres, 2003.Search in Google Scholar
10. Christensen TL, Djurhuus CB, Clayton P, Christiansen JS. An evaluation of the relationship between adult height and health-related quality of life in the general UK population. Clin Endocrinol 2007;67:407–12.10.1111/j.1365-2265.2007.02901.xSearch in Google Scholar PubMed
11. Harper B. Beauty, stature and the labor market: a British cohort study. Oxford Bull Economics Stat 2000;62:771–800.10.1111/1468-0084.0620s1771Search in Google Scholar
12. Herpin N. La taille des Hommes: son incidence sur la vie en couple et la carrière professionnelle. Economie et Statistique 2003; N° 361.10.3406/estat.2003.7355Search in Google Scholar
13. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, et al. Global Advisory Panel Meeting on the effects of growth hormone. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr 2013;102:787–96.10.1111/apa.12266Search in Google Scholar PubMed PubMed Central
14. Ranke MB, Lindberg A, Ferrández Longás A, Darendellier F, Albertsson-Wikland K, et al. KIGS International Board: major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediatr Res 2007;61:105–10.10.1203/01.pdr.0000250039.42000.c9Search in Google Scholar
15. Albertsson-Wikland K, Aronson AS, Gustafsson J, Hagenäs L, Ivarsson SA, et al. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency. J Clin Endocrinol Metab 2008;93:4342–50.10.1210/jc.2008-0707Search in Google Scholar
16. Attie KM, Bengtsson BA, Blethen SL, Blum W, Cameron F, et al. Growth Hormone Research Society. J Clin Endocrinol Metab 2000;85:3990–3.Search in Google Scholar
17. Agwu JC, Leishenring A, Darnley I. Community growth monitoring in practice. Arch Dis Child 2004;89:394.10.1136/adc.2002.022764Search in Google Scholar
18. De Onis M, Wijnhoven TM, Onyango AW. Worldwide practices in child growth monitoring. J Pediatr 2004;144:461–5.10.1016/j.jpeds.2003.12.034Search in Google Scholar
19. Sankilampi U, Saari A, Laine T, Miettinen PJ, Dunkel L. Use of electronic health records for automated screening of growth disorders in primary care. J Am Med Assoc 2013;310:1071–2.10.1001/jama.2013.218793Search in Google Scholar
20. Stoupa A, Goischke A, Garcin C, Elie C, Viaud M, et al. Can school health check-ups serve as screening tool for growth anomalies and obesity in children? J Pediatr Endocrinol Metab 2015;28:1115–21.10.1515/jpem-2014-0530Search in Google Scholar
21. De Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:660–7.10.2471/BLT.07.043497Search in Google Scholar
22. Sempé M, Pédron G, Roy-Pernot MP. Auxologie méthode et séquences. Théraplix, Paris; 1979. Réédition 1997, Méditions. ISBN: 2-905839-2.Search in Google Scholar
23. Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1969;74:901–10.10.1016/S0022-3476(69)80224-6Search in Google Scholar
24. Tanner JM. Growth at adolescence. Oxford: Blackwell, 1962.Search in Google Scholar
25. Hall DM. Growth monitoring. Arch Dis Child 2000;82:10–5.10.1136/adc.82.1.10Search in Google Scholar PubMed PubMed Central
26. Hall D, Cole T, Elliman D, Gibson P, Logan S, et al. Growth monitoring. Arch Dis Child 2008;93:717–8.10.1136/adc.82.1.10Search in Google Scholar
27. Grote FK, Oostdijk W, De Muinck Keizer-Schrama SM, van Dommelen P, van Buu Ren S, et al. The diagnostic work-up of growth failure in secondary health care; an evaluation of consensus guidelines. BMC Pediatr 2008;8:21–9.10.1186/1471-2431-8-21Search in Google Scholar PubMed PubMed Central
28. De Muinck Keizer-Schrama SM. Consensus ‘diagnosis of short stature in children’. National Organization for Quality Assurance in Hospitals (in Dutch). Ned Tijdschr Geneeskd 1998;142: 2519–25.Search in Google Scholar
29. Grote FK, van Dommelen P, Oostdijk W, de Muinck Keizer-Schrama SM, Verkerk PH, et al. Developing evidence-based guidelines for referral for short stature. Arch Dis Child 2008;93:212–7.10.1136/adc.2007.120188Search in Google Scholar PubMed
30. Mulligan J, Voss LD, McCaughey ES, Bailey BJ, Betts PR. Growth monitoring: testing the new guidelines. Arch Dis Child 1998;79:318–22.10.1136/adc.79.4.318Search in Google Scholar PubMed PubMed Central
31. Wiecha JL, Casey VA. High prevalence of overweight and short stature among head start children in Massachusetts. Public Health Rep 1994;109:767–73.Search in Google Scholar
32. Allen AD, Wallace AM. Audit of height measurement at age 3 years: results of a survey of Scottish health boards. Arch Dis Child 1996;74:332–5.10.1136/adc.74.4.332Search in Google Scholar PubMed PubMed Central
33. Oostdijk W, Grote FK, De Muinck Keizer-Schrama SM, Wit JM. Diagnostic approach in children with short stature. Horm Res 2009;72:206–17.10.1159/000236082Search in Google Scholar PubMed
34. Banerjee S, Morgan RJ, Rees SA, Latif AH. Height screening at school: ineffective without high standards and adequate resources. Arch Dis Child 2003;88:477–81.10.1136/adc.88.6.477Search in Google Scholar PubMed PubMed Central
35. Voss LD, Metcalf BS, Jeffery AN, Wilkin TJ. IOTF thresholds for overweight and obesity and their relation to metabolic risk in children (EarlyBird 20). Int J Obes 2006;30:606–9.10.1038/sj.ijo.0803187Search in Google Scholar PubMed
36. Vikram NK. Cardiovascular and metabolic complications – diagnosis and management in obese children. Indian J Pediatr 2018;85:535–45.10.1007/s12098-017-2504-0Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review
- Effect of safflower yellow on early type II diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
- Original Articles
- Genomic study via chromosomal microarray analysis in a group of Romanian patients with obesity and developmental disability/intellectual disability
- Clinical and molecular characteristics and time of diagnosis of patients with classical galactosemia in an unscreened population in Turkey
- Assessment of retinal thickness as a marker of brain masculinization in children with congenital adrenal hyperplasia: a pilot study
- Auditory event-related potentials demonstrate early cognitive impairment in children with subclinical hypothyroidism
- Cardiovascular risk factors in children with type 1 diabetes mellitus
- The relationship between serum FGF-23 concentration and insulin resistance, prediabetes and dyslipidemia in obese children and adolescents
- The metabolic consequences of overweight in a cohort of children with type 1 diabetes
- The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience
- Growth screening in children aged 3–5 years: a useful tool for public health programs in community pediatrics
- Selective receptor-mediated impairment of growth factor activity in neonatal- and X-linked adrenoleukodystrophy patients
- Determinants for low bone mineral density in pre-school children: a matched case-control study in Wuhan, China
- Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents
- Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes
- Severe, persistent neonatal hypoglycemia as a presenting feature in patients with congenital hypopituitarism: a review of our case series
- Case Reports
- Short stature in a boy with atypical progeria syndrome due to LMNA c.433G>A [p.(Glu145Lys)]: apparent growth hormone deficiency but poor response to growth hormone therapy
- A novel mutation leading to the lethal form of carnitine palmitoyltransferase type-2 deficiency
- Diagnosis of cyclic Cushing’s disease manifests as early morning hyperglycemia in a patient with previously well-controlled type 1 diabetes
- Short Communication
- Replacement of breastfeeding with medical food for the treatment of galactosemia and phenylketonuria: maternal stress
Articles in the same Issue
- Frontmatter
- Review
- Effect of safflower yellow on early type II diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
- Original Articles
- Genomic study via chromosomal microarray analysis in a group of Romanian patients with obesity and developmental disability/intellectual disability
- Clinical and molecular characteristics and time of diagnosis of patients with classical galactosemia in an unscreened population in Turkey
- Assessment of retinal thickness as a marker of brain masculinization in children with congenital adrenal hyperplasia: a pilot study
- Auditory event-related potentials demonstrate early cognitive impairment in children with subclinical hypothyroidism
- Cardiovascular risk factors in children with type 1 diabetes mellitus
- The relationship between serum FGF-23 concentration and insulin resistance, prediabetes and dyslipidemia in obese children and adolescents
- The metabolic consequences of overweight in a cohort of children with type 1 diabetes
- The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience
- Growth screening in children aged 3–5 years: a useful tool for public health programs in community pediatrics
- Selective receptor-mediated impairment of growth factor activity in neonatal- and X-linked adrenoleukodystrophy patients
- Determinants for low bone mineral density in pre-school children: a matched case-control study in Wuhan, China
- Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents
- Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes
- Severe, persistent neonatal hypoglycemia as a presenting feature in patients with congenital hypopituitarism: a review of our case series
- Case Reports
- Short stature in a boy with atypical progeria syndrome due to LMNA c.433G>A [p.(Glu145Lys)]: apparent growth hormone deficiency but poor response to growth hormone therapy
- A novel mutation leading to the lethal form of carnitine palmitoyltransferase type-2 deficiency
- Diagnosis of cyclic Cushing’s disease manifests as early morning hyperglycemia in a patient with previously well-controlled type 1 diabetes
- Short Communication
- Replacement of breastfeeding with medical food for the treatment of galactosemia and phenylketonuria: maternal stress
